
Reset all filters
01 2Artelac
Carbomer Medium Chain Triglycerides
Main Therapeutic Indication : Ophthalmology
Currency : USD
2020 Revenue in Millions : 95
2019 Revenue in Millions : 94
Growth (%) : 1
Carbomer Medium Chain Triglycerides
Main Therapeutic Indication : Ophthalmology
Currency : USD
2021 Revenue in Millions : 113
2020 Revenue in Millions : 99
Growth (%) : 14